These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37305891)

  • 21. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
    Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
    Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.
    Kim JE; Min YG; Shin JY; Kwon YN; Bae JS; Sung JJ; Hong YH
    Front Neurol; 2021; 12():820723. PubMed ID: 35153993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
    Zubair AS; Bae JY; Desai K
    Cureus; 2022 Feb; 14(2):e22341. PubMed ID: 35371813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
    Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
    J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis.
    Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
    J Neurol; 2024 Mar; 271(3):1063-1071. PubMed ID: 38233678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
    Jaffry M; Mostafa F; Mandava K; Rosario S; Jagarlamudi Y; Jaffry K; Kornitzer J; Jedidi K; Khan H; Souayah N
    Vaccine; 2022 Sep; 40(40):5791-5797. PubMed ID: 36055875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-COVID-19 Guillain-Barré Syndrome: A Case Report With Literature Review.
    Kaeley N; Kabi A; Pillai A; Shankar T; Ameena M S S
    Cureus; 2022 Jan; 14(1):e21246. PubMed ID: 35178309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-​Barré Syndrome Associated with COVID-19 Vaccination.
    Shao SC; Wang CH; Chang KC; Hung MJ; Chen HY; Liao SC
    Emerg Infect Dis; 2021 Dec; 27(12):3175-3178. PubMed ID: 34648420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
    Magira EE; Papaioakim M; Nachamkin I; Asbury AK; Li CY; Ho TW; Griffin JW; McKhann GM; Monos DS
    J Immunol; 2003 Mar; 170(6):3074-80. PubMed ID: 12626563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria.
    López-Hernández JC; Galnares-Olalde JA; Gutiérrez A; Estrada SA; García-Grimshaw M; Vargas-Cañas ES
    Rev Neurol; 2022 Apr; 74(8):258-264. PubMed ID: 35383873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: Guillain-Barré Syndrome Associated With COVID-19.
    Khedr EM; Shoyb A; Mohamed KO; Karim AA; Saber M
    Front Neurol; 2021; 12():678136. PubMed ID: 34239495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.